PARDES BIOSCIENCES
Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. The company’s lead product candidate, PBI-0451, is being developed as a direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections, the virus responsible for COVID-19. Pardes Biosciences is on a mission to stop a pandemic and start a movement so patients everywhere can get well sooner.
PARDES BIOSCIENCES
Social Links:
Industry:
Biotechnology Life Science
Founded:
2020-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.pardesbio.com
Total Employee:
1+
Status:
Active
Contact:
415-649-8758
Total Funding:
126.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Walden Biosciences
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Pardes Biosciences
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Pardes Biosciences
GMF Capital
GMF Capital investment in Post-IPO Equity - Pardes Biosciences
Gilead Sciences
Gilead Sciences investment in Post-IPO Equity - Pardes Biosciences
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Pardes Biosciences
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Pardes Biosciences
Foresite Capital
Foresite Capital investment in Post-IPO Equity - Pardes Biosciences
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - Pardes Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-02 | Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board |
| 2021-11-30 | Pardes Biosciences Appoints New Chief Business and Strategy Officer |
Official Site Inspections
http://www.pardesbio.com Semrush global rank: 3.57 M Semrush visits lastest month: 4.07 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pardes Biosciences"
Pardes Biosciences - Crunchbase Company Profile
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.See details»
Pardes Biosciences - Overview, News & Similar companies
Mar 2, 2022 View Pardes Biosciences (www.pardesbio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Pardes Biosciences 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Pardes Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Pardes Biosciences Company Profile | Management and ... - Datanyze
Find contact information for Pardes Biosciences. Learn about their Research & Development, Business Services market share, competitors, and Pardes Biosciences's email format.See details»
Pardes Biosciences - Org Chart, Teams, Culture & Jobs | The Org
View Pardes Biosciences' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Pardes Biosciences Company Overview, Contact Details
Dec 27, 2021 Learn more about Pardes Biosciences's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Pardes Biosciences - businessabc
Feb 25, 2025 Pardes Biosciences was founded in 2012 with the aim of developing personalized treatments for cancer. Since then, the company has made significant progress in the field, …See details»
Pardes Biosciences Overview | SignalHire Company Profile
Pardes Biosciences is a private company that has been in the industry for 4 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Founder & …See details»
Pardes Biosciences - Products, Competitors, Financials, Employees ...
Pardes Biosciences is a clinical-stage biopharmaceutical company focused on addressing pandemic-sized problems, primarily COVID-19, within the healthcare sector. Use the CB …See details»
About PARDES BIOSCIENCES, INC. | DxMultiomics
PARDES BIOSCIENCES, INC. | on DxMultiomics. Pardes Biosciences is a biopharmaceutical company that has been focused on discovering, developing and commercializing novel oral …See details»
Pardes Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
For more information, please visit www.pardesbio.com. Cautionary Notice Regarding Forward-Looking Statements This communication contains “forward-looking statements” relating to the …See details»
Pardes Biosciences - VentureRadar
Pardes Biosciences is a clinical-stage biopharmaceutical company committed to solving some of the world’s most pressing public health challenges. Pardes leverages structure-based drug …See details»
Pardes Biosciences – Funding, Valuation, Investors, News
Jan 10, 2022 Essential stats, news, real-time insights on Pardes Biosciences. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Pardes Biosciences Inc. - Cruelty Free Investing
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. The …See details»
Pardes Biosciences Enters into Agreement to be Acquired by
Jul 17, 2023 The Company intends to use the Investors page of its website (https://ir.pardesbio.com) as a means of disclosing material non-public information and for …See details»
Pardes Biosciences - News, Mergers and Acquisitions, Locations …
Usearch identified 1 signals for Pardes Biosciences, including: 1 Mergers and Acquisitions. Usearch has identified 2 executives & key decision-makers.See details»
Pardes Biosciences and FS Development Corp. II Announce
Jun 29, 2021 Pardes Biosciences, Inc., an early-stage biopharmaceutical company, and FS Development Corp. II, a special purpose acquisition company sponsored by Foresite Capital, …See details»
Pardes Biosciences Legend – Foresite Capital
About Pardes Biosciences Pardes Biosciences is a clinical-stage biopharmaceutical company committed to solving some of the world’s most pressing public health challenges. Pardes …See details»
Pardes Biosciences – Funding, Valuation, Investors, News | Parsers VC
Jan 10, 2022 Pardes Biosciences is an agile biopharmaceutical company committed to solving some of the world’s most pressing public health challenges. Pardes leverages structure-based …See details»
Pardes Biosciences Reports Fourth Quarter and Full Year
Mar 14, 2023 Pardes Biosciences intends to use the Investors page of its website (https://ir.pardesbio.com) as a means of disclosing material non-public information and for …See details»